These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 18827908

  • 1. Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.
    Ban CR, Twigg SM.
    Vasc Health Risk Manag; 2008; 4(3):575-96. PubMed ID: 18827908
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thrombospondin-1: A Key Protein That Induces Fibrosis in Diabetic Complications.
    Xu L, Zhang Y, Chen J, Xu Y.
    J Diabetes Res; 2020; 2020():8043135. PubMed ID: 32626782
    [Abstract] [Full Text] [Related]

  • 4. [Basal membrane and diabetes mellitus].
    Masmiquel L, Burgos R, Simó R.
    Med Clin (Barc); 1997 Sep 13; 109(8):302-10. PubMed ID: 9379754
    [No Abstract] [Full Text] [Related]

  • 5. Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus.
    Twigg SM, Chen MM, Joly AH, Chakrapani SD, Tsubaki J, Kim HS, Oh Y, Rosenfeld RG.
    Endocrinology; 2001 May 13; 142(5):1760-9. PubMed ID: 11316739
    [Abstract] [Full Text] [Related]

  • 6. Microvascular basement membranes in diabetes mellitus.
    Tsilibary EC.
    J Pathol; 2003 Jul 13; 200(4):537-46. PubMed ID: 12845621
    [Abstract] [Full Text] [Related]

  • 7. Diabetic microvascular complications and growth factors.
    Pfeiffer A, Schatz H.
    Exp Clin Endocrinol Diabetes; 1995 Jul 13; 103(1):7-14. PubMed ID: 7621107
    [Abstract] [Full Text] [Related]

  • 8. Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure.
    Aronson D.
    Med Hypotheses; 2002 Sep 13; 59(3):297-301. PubMed ID: 12208156
    [Abstract] [Full Text] [Related]

  • 9. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ, Kang MK, Kim DY, Kim YH, Oh H, Kang YH.
    Nutrients; 2018 Jul 09; 10(7):. PubMed ID: 29987200
    [Abstract] [Full Text] [Related]

  • 10. The role of advanced glycation in the pathogenesis of diabetic retinopathy.
    Stitt AW.
    Exp Mol Pathol; 2003 Aug 09; 75(1):95-108. PubMed ID: 12834631
    [Abstract] [Full Text] [Related]

  • 11. Hyperglycemia and microangiopathy. Direct regulation by glucose of microvascular cells.
    Kreisberg JI.
    Lab Invest; 1992 Oct 09; 67(4):416-26. PubMed ID: 1434526
    [No Abstract] [Full Text] [Related]

  • 12. Vascular fibrosis in atherosclerosis.
    Lan TH, Huang XQ, Tan HM.
    Cardiovasc Pathol; 2013 Oct 09; 22(5):401-7. PubMed ID: 23375582
    [Abstract] [Full Text] [Related]

  • 13. [The significance of compensation in diabetes mellitus in the development of diabetic microangiopathies (a review of the literature)].
    Gendeleka GF.
    Vrach Delo; 1989 Aug 09; (8):54-8. PubMed ID: 2686158
    [No Abstract] [Full Text] [Related]

  • 14. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K.
    J Cell Physiol; 2005 May 09; 203(2):447-56. PubMed ID: 15605379
    [Abstract] [Full Text] [Related]

  • 15. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.
    Thomson SE, McLennan SV, Kirwan PD, Heffernan SJ, Hennessy A, Yue DK, Twigg SM.
    J Diabetes Complications; 2008 May 09; 22(4):284-94. PubMed ID: 18413184
    [Abstract] [Full Text] [Related]

  • 16. High glucose upregulates connective tissue growth factor expression in human vascular smooth muscle cells.
    Liu X, Luo F, Pan K, Wu W, Chen H.
    BMC Cell Biol; 2007 Jan 16; 8():1. PubMed ID: 17224075
    [Abstract] [Full Text] [Related]

  • 17. Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy.
    Williamson JR, Tilton RG, Chang K, Kilo C.
    Diabetes Metab Rev; 1988 Jun 16; 4(4):339-70. PubMed ID: 3292174
    [No Abstract] [Full Text] [Related]

  • 18. TAGE (toxic AGEs) theory in diabetic complications.
    Sato T, Iwaki M, Shimogaito N, Wu X, Yamagishi S, Takeuchi M.
    Curr Mol Med; 2006 May 16; 6(3):351-8. PubMed ID: 16712480
    [Abstract] [Full Text] [Related]

  • 19. [Advanced glycation end products and hyperglycaemia].
    Omsland TK, Bangstad HJ, Berg TJ, Kolset SO.
    Tidsskr Nor Laegeforen; 2006 Jan 12; 126(2):155-8. PubMed ID: 16415936
    [Abstract] [Full Text] [Related]

  • 20. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease.
    Cooper ME.
    Am J Hypertens; 2004 Dec 12; 17(12 Pt 2):31S-38S. PubMed ID: 15607433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.